eNauka - pregled
Pregled prema Autor Hadji, Peyman
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2025 | Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG | Hadji, Peyman; ...; Matijevic, Radmila   ; ...; (broj, koautora 32) | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2017 | Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications | Stefanovic, Stefan; Wallwiener, Markus; Karic, Uros ; Domschke, Christoph; Katic, Luka; Taran, Florin-Andrei; Pesic, Aleksandra; Hartkopf, Andreas; Hadji, Peyman; Teufel, Martin;
Schuetz, Florian; Sohn, Christof; Fasching, Peter; Schneeweiss, Andreas; Brucker, Sara;
| Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |